Q: What is the Genotyping market size in year 2021?

The Genotyping market size was $12,650 million in 2021.

Q: What is the CAGR for the Genotyping market?

The Genotyping market is expected to grow at a CAGR of 15.42% during 2023-2032.

Q: What are the segments covered in the Genotyping market report?

Market.US has segmented the Genotyping market by geography (North America, Europe, APAC, South America, and the Middle East and Africa). By Product, the market has been segmented into instruments, reagents & kits, and software & services. By Technology, the market has been further divided into pcr, capillary electrophoresis, microarray, sequencing, mass spectrometry, other technologies. By Application, the market has been further divided into pharmacogenomics, diagnostics and personalized medicine, agricultural biotechnology, animal genetics, and other applications. By End-Use, the market has been further divided into pharmaceutical and biopharmaceutical companies, diagnostics and research laboratories, academic institutes, other end-uses.

Q: Who are the key players in the Genotyping market?

Illumina Inc., Thermo Fisher Scientific Inc., Qiagen Inc., F. Hoffmann-La Roche Ltd., Fluidigm Corporation, Danaher Corporation, Agilent Technologies, Eurofins Scientific Inc., and Other Key Players

Q: Which region is more attractive for vendors in the Genotyping market?

North America accounted for the highest revenue share of 32% among the other regions. Therefore, North America Genotyping market is expected to garner significant business opportunities for the vendors during the forecast period.

Q: What are the key markets for Genotyping ?

Key markets for Genotyping are US, China, Japan, India, Brazil, Germany, UK, France, Italy, Spain, etc.

Q: Which segment has the largest share in the Genotyping market?

In the Genotyping market, vendors should focus on grabbing business opportunities from the reagents & kits product segment as it accounted for the largest market share in the base year.

Global Genotyping Market By Product (Instruments, Reagents & Kits, and Software & Services), By Technology (PCR, Capillary Electrophoresis, Microarray, Sequencing, Mass Spectrometry, and Other Technologies), By Application (Plastics, Inks, and Coatings), By Application (Pharmacogenomics, Diagnostics And Personalized Medicine, Agricultural Biotechnology, Animal Genetics, and Other Applications), By End-Use (Pharmaceutical And Biopharmaceutical Companies, Diagnostics And Research Laboratories, Academic Institutes, and Other End-Uses), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Published date: Aug 2022
Report ID: 41073
Number of Pages: 351
Format:

- 1. Genotyping Market Introduction
  - 1.1. Definition
  - 1.2. Taxonomy
  - 1.3. Research Scope
- 2. Executive Summary
  - 2.1. Key Findings by Major Segments
  - 2.2. Top strategies by Major Players
- 3. Global Genotyping Market Overview
  - 3.1. Genotyping Market Dynamics
    3.1.1. Drivers
    3.1.2. Opportunities
    3.1.3. Restraints
    3.1.4. Challenges
  - 3.2. PESTLE Analysis
  - 3.3. Opportunity Map Analysis
  - 3.4. PORTER'S Five Forces Analysis
  - 3.5. Market Competition Scenario Analysis
  - 3.6. Product Life Cycle Analysis
  - 3.7. Opportunity Orbits
  - 3.8. Production Analysis by Region/Company
  - 3.9. Industry chain Analysis
  - 3.10. Marketing Strategy
- 4. Global Genotyping Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
  - 4.1. Global Genotyping Market Analysis by Type: Introduction
  - 4.2. Market Size and Forecast by Region
  - 4.3. Polymerase Chain Reaction
  - 4.4. Sequencing
  - 4.5. Microarray
  - 4.6. Electrophoresis
  - 4.7. MALDI-TOF
- 5. Global Genotyping Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
  - 5.1. Global Genotyping Market Analysis by Application: Introduction
  - 5.2. Market Size and Forecast by Region
  - 5.3. Pharmacogenomics
  - 5.4. Diagnostic Research
  - 5.5. Animal Genetics
  - 5.6. Agricultural Biotechnology
- 6. Global Genotyping Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
  - 6.1. North America
    6.1.1. North America Genotyping Market: Regional Trend Analysis
    6.1.1.1. US
    6.1.1.2. Canada
    6.1.1.3. Mexico
  - 6.2.1. Europe
    6.2.1. Europe Genotyping Market: Regional Trend Analysis
    6.2.1.1. Germany
    6.2.1.2. France
    6.2.1.3. UK
    6.2.1.4. Russia
    6.2.1.5. Italy
    6.2.1.6. Spain
    6.2.1.7. Rest of Europe
  - 6.3. Asia-Pacific
    6.3.1. Asia-Pacific Genotyping Market: Regional Trend Analysis
    6.3.1.1. China
    6.3.1.2. Japan
    6.3.1.3. Korea
    6.3.1.4. India
    6.3.1.5. Rest of Asia-Pacific
  - 6.4. Latin America
    6.4.1. Latin America Genotyping Market: Regional Trend Analysis
    6.4.1.1. Brazil
    6.4.1.2. Argentina
    6.4.1.3. Rest of Latin America
  - 6.5. Middle East and Africa
    6.5.1. Middle East and Africa Genotyping Market: Regional Trend Analysis
    6.5.1.1. GCC
    6.5.1.2. South Africa
    6.5.1.3. Israel
    6.5.1.4. Rest of MEA
- 7. Global Genotyping Market Competitive Landscape, Market Share Analysis, and Company Profiles
  - 7.1. Market Share Analysis
  - 7.2. Company Profiles
  - 7.3. Illumina
    7.3.1. Company Overview
    7.3.2. Financial Highlights
    7.3.3. Product Portfolio
    7.3.4. SWOT Analysis
    7.3.5. Key Strategies and Developments
  - 7.4. Affymetrix
    7.4.1. Company Overview
    7.4.2. Financial Highlights
    7.4.3. Product Portfolio
    7.4.4. SWOT Analysis
    7.4.5. Key Strategies and Developments
  - 7.5. Life Technologies
    7.5.1. Company Overview
    7.5.2. Financial Highlights
    7.5.3. Product Portfolio
    7.5.4. SWOT Analysis
    7.5.5. Key Strategies and Developments
  - 7.6. Agilent Technologies
    7.6.1. Company Overview
    7.6.2. Financial Highlights
    7.6.3. Product Portfolio
    7.6.4. SWOT Analysis
    7.6.5. Key Strategies and Developments
  - 7.7. Qiagen
    7.7.1. Company Overview
    7.7.2. Financial Highlights
    7.7.3. Product Portfolio
    7.7.4. SWOT Analysis
    7.7.5. Key Strategies and Developments
  - 7.8. Sequenom
    7.8.1. Company Overview
    7.8.2. Financial Highlights
    7.8.3. Product Portfolio
    7.8.4. SWOT Analysis
    7.8.5. Key Strategies and Developments
  - 7.9. Fluidigm
    7.9.1. Company Overview
    7.9.2. Financial Highlights
    7.9.3. Product Portfolio
    7.9.4. SWOT Analysis
    7.9.5. Key Strategies and Developments
  - 7.10. Beckman Coulter
    7.10.1. Company Overview
    7.10.2. Financial Highlights
    7.10.3. Product Portfolio
    7.10.4. SWOT Analysis
    7.10.5. Key Strategies and Developments
  - 7.11. Roche
    7.11.1. Company Overview
    7.11.2. Financial Highlights
    7.11.3. Product Portfolio
    7.11.4. SWOT Analysis
    7.11.5. Key Strategies and Developments
  - 7.12. GE Healthcare
    7.12.1. Company Overview
    7.12.2. Financial Highlights
    7.12.3. Product Portfolio
    7.12.4. SWOT Analysis
    7.12.5. Key Strategies and Developments
- 8. Assumptions and Acronyms
- 9. Research Methodology
- 10. Contact
- Illumina Inc.
- Thermo Fisher Scientific Company Profile
- Qiagen Inc.
- F. Hoffmann-La Roche Ltd.
- Fluidigm Corporation
- Danaher Corporation Company Profile
- Agilent Technologies Inc. Company Profile
- Eurofins Scientific Inc.
- Other Key Players
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $5,999 $2,999 USD / per unit save 50%	Multi User $7,999 $3,499 USD / per unit save 55%	Corporate User $12,999 $4,499 USD / per unit save 65%
e-Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 2,999)	Buy Now ($ 3,499)	Buy Now ($ 4,499)